Presentation is loading. Please wait.

Presentation is loading. Please wait.

Malignant Triton Tumor of the Brachial Plexus Invading the Left Thoracic Inlet: A Rare Differential Diagnosis of Pancoast Tumor  Jo Dartnell, BSc, MRCS,

Published byAshlee Haynes Modified over 5 years ago

Similar presentations

Presentation on theme: "Malignant Triton Tumor of the Brachial Plexus Invading the Left Thoracic Inlet: A Rare Differential Diagnosis of Pancoast Tumor  Jo Dartnell, BSc, MRCS,"— Presentation transcript:

1 Malignant Triton Tumor of the Brachial Plexus Invading the Left Thoracic Inlet: A Rare Differential Diagnosis of Pancoast Tumor  Jo Dartnell, BSc, MRCS, John Pilling, FRCS (CTh), Rosalie Ferner, MD, FRCP, Paul Cane, BMedSci, FRCP(Path), Loïc Lang- Lazdunski, MD, PhD, FRCS  Journal of Thoracic Oncology  Volume 4, Issue 1, Pages (January 2009) DOI: /JTO.0b013e ab Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Magnetic resonance imaging (MRI) and computed tomography (CT) showing the large neurogenic tumor arising from the thoracic inlet in close contact with the subclavian vessels and aortic arch but not invading the left upper lobe. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e ab) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Positron emission tomography-computed tomography (PET-CT) showing a large 9 × 7.3 cm Fluorodeoxyglucose (FDG) avid tumor in the left upper thoracic cavity. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e ab) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 The surgically resected specimen (371 g; 135 × 90 × 60 mm) completely resected en bloc with mediastinal tissue, scalene muscles and the lower cord of the brachial plexus. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e ab) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Histopathology (hematoxylin and eosin × 100). Arrows pointing to the scattered large round cells with eosinophilic cytoplasm representing rhabdomyoblasts among the spindle cells. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e ab) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Malignant Triton Tumor of the Brachial Plexus Invading the Left Thoracic Inlet: A Rare Differential Diagnosis of Pancoast Tumor  Jo Dartnell, BSc, MRCS,"

Similar presentations

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 
Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment  Tjeerd S. Aukema, MD, Renato.

Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment  Tjeerd S. Aukema, MD, Renato.
Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus

Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus
Akos Varga-Szemes, MD, PhD, U. Joseph Schoepf, MD, Laura S

Akos Varga-Szemes, MD, PhD, U. Joseph Schoepf, MD, Laura S
Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist.

Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Invasive Inflammatory Myofibroblastic Tumor of the Lung

Invasive Inflammatory Myofibroblastic Tumor of the Lung
Unilateral Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Multiple Carcinoids Treated with Surgical Resection  Sheeba Irshad, Emma McLean,

Unilateral Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Multiple Carcinoids Treated with Surgical Resection  Sheeba Irshad, Emma McLean,
Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation  Andrea L.H. Arnett, MD, PhD, Kenneth.

Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation  Andrea L.H. Arnett, MD, PhD, Kenneth.
Metastases to Breast from Primary Lung Cancer

Metastases to Breast from Primary Lung Cancer
Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 
David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F
Exogenous Lipoid Pneumonia Mimicking Multifocal Bronchogenic Carcinoma

Exogenous Lipoid Pneumonia Mimicking Multifocal Bronchogenic Carcinoma
Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,

Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,
Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Zeynep Eroglu, MD, Jae Kim, MD, Sharon Wilczynski, MD, PhD, Warren A

Zeynep Eroglu, MD, Jae Kim, MD, Sharon Wilczynski, MD, PhD, Warren A
Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT  Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,

Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT  Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.

Similar presentations

Ads by Google